| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |